Min Min Yang
Director Ejecutivo en PHARMABLOCK SCIENCES (NANJING), INC. .
Fortuna: 192 M $ al 30/04/2024
Perfil
Fundador de PharmaBlock Sciences (Nanjing), Inc., Min Min Yang es presidente de esta empresa. También forma parte del consejo de administración de Shanghai Ark Biopharmaceutical Co.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
03/07/2023 | 30 980 300 ( 99.23% ) | 144 M $ | 30/04/2024 | |
03/07/2023 | 10 326 800 ( 6.13% ) | 48 M $ | 30/04/2024 |
Cargos activos de Min Min Yang
Empresas | Cargo | Inicio |
---|---|---|
PHARMABLOCK SCIENCES (NANJING), INC. | Director Ejecutivo | 21/04/2023 |
GEMPHARMATECH CO., LTD. | Director/Miembro de la Junta | 19/10/2023 |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Director/Miembro de la Junta | 01/03/2021 |
Formación de Min Min Yang.
Nanjing University | Graduate Degree |
Auburn University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
PHARMABLOCK SCIENCES (NANJING), INC. | Commercial Services |
GEMPHARMATECH CO., LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Health Technology |
- Bolsa de valores
- Insiders
- Min Min Yang